Takeda gets Japanese NDA approval for obesity drug

Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labo...

September 23, 2013 | Monday | News
MHRA issues import alert to Wockhardt's India plant

Singapore: About two months after the US Food and Drug Administration (US FDA) issued a Form 483 to Wockhardt for drug q...

July 9, 2013 | Tuesday | Regulatory
Irish firm's track-&-trace system to curb fake drugs

Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at ...

June 19, 2013 | Wednesday | News
Mylan launches generic version of Sporanox

Singapore: Mylan Pharmaceuticals received final approval from the US FDA for its abbreviated new drug application (ANDA)...

July 30, 2012 | Monday | Regulatory
Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand

Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...

April 24, 2013 | Wednesday | News
AstraZeneca, BMS gets FDA nod for diabetes drug

Singapore: AstraZeneca and Bristol-Myers Squibb have recieved U.S. Food and Drug Administration (FDA) approval for diabe...

January 9, 2014 | Thursday | Regulatory
Ranbaxy advisory: All our products are safe and efficacious

New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...

June 3, 2013 | Monday | News
Rabies claims 100 lives annually in Vietnam: UN

Singapore: Vietnam has seen a substantial increase in the number of rabies fatalities from 34 deaths in 2003 to 131 deat...

September 30, 2013 | Monday | Analysis
Now Ranbaxy's Mohali unit under FDA scanner

Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, se...

June 24, 2013 | Monday | News
Mundipharma, Shionogi tie up for pain treatment in Japan

Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...

November 22, 2013 | Friday | News
GSK files for approval on melanoma drug combo

Singapore: Britian's leading drug maker, GlaxoSmithKline has filed for US Food and Drug Administration (US FDA) approval...

July 10, 2013 | Wednesday | News
TB prevention faces gap of $1.6bn: WHO estimates

Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...

April 24, 2013 | Wednesday | News
Avanir Pharma settles patent litigation with Wockhardt

Singapore: US based Avanir Pharmaceuticals has entered into a settlement agreement with India's Wockhardt to resolve pen...

September 9, 2013 | Monday | News
TWi Pharma gets FDA nod for ADHD drug

Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (AN...

May 15, 2013 | Wednesday | News
Sandoz launches trial with Amgen biosimilar

Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's...

June 26, 2013 | Wednesday | News
US company leverages on generics

Singapore: US based Par Pharmaceutical has entered into agreements with Watson Pharmaceuticals and Actavis Group to purc...

April 24, 2012 | Tuesday | News
NATCO wins compulsory license for anti-cancer drug

In a landmark decision, Hyderabad-based NATCO Pharma has been granted compulsory license for Sorafenib Tosylate sold und...

March 16, 2012 | Friday | News
Mylan gets FDA nod for Thiamine Hydrochloride Injection

Singapore: Mylan Institutional business has received final approval from the US Food and Drug Administration (FDA) for ...

July 2, 2012 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls